Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

FDA puts gastric implants on device shortages list, adds Resmed product discontinuation

November 18, 2026 By Skyler Rivera

The Enterra II gastric electrical stimulation implant system.

Enterra Medical describes its Enterra II implant as “an advanced therapy option that is designed to relieve nausea and vomiting symptoms of gastroparesis.” [Image courtesy of Enterra Medical]

The FDA updated its device shortages and discontinued devices list, adding implantable gastric electrical stimulation systems (product code LNQ) and removing angiographic control syringes with rotating adapters (product code DXT).

The agency also added 11 new product codes to its medical device discontinuance list. Among FDA’s latest additions to the list of permanently discontinued devices are Abbott CPS Direct percutaneous catheters, SunMed Group Holdings arterial blood sampling kits and Resmed’s Astral 100 and Astral 150 ventilators.

ResMed discontinued its Astral ventilator portfolio in September 2026, just a few months after warning patients to stop using certain Astral 100 (model No. 27001) and Astral 150 (model no. 27003) ventilators after identifying an issue related to the printed circuit board assembly that could cause the ventilator to enter a fail-safe state. FDA later classified the issue as a Class I recall, the most serious type, following at least five serious injuries.

Explaining the discontinuation, Resmed told customers it assessed its long-term component supply outlook and that “ongoing supply constraints affecting critical electronic components have created significant challenges for the continued manufacture of Astral ventilators.”

Implantable gastric electrical stimulation system developer Enterra Medical also cited a shortage of electronic components needed to manufacture its Enterra II neurostimulator. Due to the shortage, FDA has allowed Enterra Medical to distribute its next-generation Enterra Ascent system for patient use while it undergoes FDA review.

“Enterra Ascent may be distributed under an FDA enforcement policy for medical device supply shortages while the FDA’s review of the Enterra Ascent submission continues,” the company said in a statement. “This does not mean that FDA has approved Enterra Ascent or made any determination about its safety or probable benefit.”

The company said Enterra II is no longer available, and that Enterra Ascent is intended to provide the same treatment, but has design changes that have not yet been fully reviewed by the FDA. Enterra Medical said patient safety is its highest priority and that patients should consult their physician before use.

“There is limited experience with use of Enterra Ascent in humans,” Enterra Medical says. “Although your doctor will discuss the potential risks of the device with you, there may be other risks, side effects, or complications that are currently unknown or unexpected.”

Related: A boy’s death is a tragic example of foreseeable risk in device design

The company expected shipments of the next-generation device to begin in November 2026, with limited initial supply. Enterra Medical said it’s increasing manufacturing of the device and expects availability to improve over the coming weeks and months, but it expected demand to remain higher than supply.

“Because many patients are already waiting for treatment, demand is expected to far exceed available supply early on,” the company said. “… timing will depend on several factors, including manufacturing output and demand. Enterra Medical cannot guarantee when a device will be available for any individual patient.”

FDA expects the shortage to last through the fourth quarter of 2027.

June 2026: FDA device shortage update includes bloodlines, biopsy needles and more

About The Author

Skyler Rivera

Skyler Rivera is an associate editor at Arrowfly, covering medical device industry news and technology at MassDevice and Medical Design & Outsourcing. She began her career covering sports at The Athletic and MLB before transitioning to medical writing at Edwards Lifesciences. Based in Southern California, she holds a master's degree in science writing from Johns Hopkins University and a bachelor’s in broadcast journalism from Syracuse University. Connect with her on LinkedIn or email at [email protected].

Related Articles Read More >

The Virtuoso System endoscope tip with manipulators,
Tiny, superelastic nitinol arms make this breakthrough surgical robot possible
The pitch: Cerulean Scientific’s failure-resistant intraventricular catheter
An illustration showing the Autus size-adjustable heart valve being expanded years after implantation with a minimally invasive balloon catheter.
The first-of-its-kind Autus pediatric heart valve is designed for expansion and durability
A photo of FDA Associate Director for TAP April Marrone.
How device innovators can make the most of FDA’s TAP accelerator
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe